Evident Vascular, a San Jose, CA-based medical technology startup developing an intravascular ultrasound (IVUS) platform, raised $35M in Series A funding.
The round was led by Vensana Capital.
The company intends to use the funds to expand operations, the R&D sector, and its business reach.
Led by Howard Rosen, CEO, Chief Technology Officer Patrick Phillips, Ph.D., and Chief Product Officer Danielo Piazza, Evident Vascular is developing an intravascular ultrasound (IVUS) platform technology designed initially for peripheral vascular interventions, with future capability for coronary procedures. Leveraging artificial intelligence (AI) to enable image interpretation and streamlined workflows, the technology has been designed to expand adoption of IVUS, driving increased market penetration and enabling improved clinical outcomes with faster, more accurate diagnosis and treatment decisions.
FinSMEs
17/10/2023